Weight Loss

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Metformin plus lifestyle produced significant weight loss from baseline (-3.4 kg, 95% CI: -5.3, -1.5) at 6 months, but this was not significantly different from placebo plus lifestyle, indicating no a

Effect: null; -3.4 kg from baseline in MET at 6 months; CI: 95% CI: (-5.3, -1.5)

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null

Age, gender, and BMI were not significant predictors of weight loss at months 4 or 7 following a DPP-adapted lifestyle intervention in prediabetic adults.

Effect: null